FDA

WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images)
A man receives a H1N1 swine flu vaccine at XXXXX on October 27, 2009 in Seoul, South Korea. The Korea Food and Drug Administration approved domestically developped vaccines last week, the government plan to vaccinate 35 percent of South Korean population until next February.
Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, rest on a lab table at the Kaiser Permanente Washington Health Research Institute in Seattle on Monday, March 16, 2020. (AP Photo/Ted S. Warren)
Keep An Eye On This Prime Badge
By | September 4, 2020 3:57 p.m.
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: